Phase 2a atudy of Thykamine (PUR-0110) in patients with mild-to-moderate Atopic Dermatitis (AD)
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2017
At a glance
- Drugs Thykamine (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- 03 Jul 2017 New trial record
- 22 Jun 2017 According to a Devonian Health Group media release, this study is planned to start in end of june 2017.
- 22 Jun 2017 According to a Devonian Health Group media release, JSS Medical Research Inc. will work as CRO for this trial.